title: Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.
authors.forename: G H
authors.initials: GH
authors.lastname: Struijk
authors.forename: A H M
authors.initials: AH
authors.lastname: Bouts
authors.forename: G T
authors.initials: GT
authors.lastname: Rijkers
authors.forename: E A C
authors.initials: EA
authors.lastname: Kuin
authors.forename: I J M
authors.initials: IJ
authors.lastname: ten Berge
authors.forename: F J
authors.initials: FJ
authors.lastname: Bemelman
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D065766:Atypical Hemolytic Uremic Syndrome; D005260:Female; D005919:Glomerular Filtration Rate; D006084:Graft Rejection / Q000188:drug therapy / Q000209:etiology*; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000601:surgery*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000009:adverse effects*; D008589:Meningococcal Infections / Q000209:etiology* / Q000517:prevention & control; D022401:Meningococcal Vaccines / Q000008:administration & dosage; D011379:Prognosis; D012307:Risk Factors; D018805:Sepsis / Q000209:etiology* / Q000517:prevention & control; D013997:Time Factors; D014611:Vaccination; D055815:Young Adult
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D022401:Meningococcal Vaccines; C481642:eculizumab